DK2212352T3 - Nye syntetiske argininsubstituerede peptider og deres anvendelse - Google Patents

Nye syntetiske argininsubstituerede peptider og deres anvendelse

Info

Publication number
DK2212352T3
DK2212352T3 DK08850370.1T DK08850370T DK2212352T3 DK 2212352 T3 DK2212352 T3 DK 2212352T3 DK 08850370 T DK08850370 T DK 08850370T DK 2212352 T3 DK2212352 T3 DK 2212352T3
Authority
DK
Denmark
Prior art keywords
novel synthetic
substituted peptides
synthetic arginine
arginine
peptides
Prior art date
Application number
DK08850370.1T
Other languages
English (en)
Inventor
Inger Mattsby-Baltzer
Gunnar Dolphin
Original Assignee
Inger Mattsby-Baltzer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inger Mattsby-Baltzer filed Critical Inger Mattsby-Baltzer
Application granted granted Critical
Publication of DK2212352T3 publication Critical patent/DK2212352T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK08850370.1T 2007-11-14 2008-11-10 Nye syntetiske argininsubstituerede peptider og deres anvendelse DK2212352T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07120713A EP2060586A1 (en) 2007-11-14 2007-11-14 New synthetic arginine substituted peptides and their use
US99006607P 2007-11-26 2007-11-26
PCT/EP2008/065186 WO2009062898A1 (en) 2007-11-14 2008-11-10 New synthetic arginine substituted peptides and their use

Publications (1)

Publication Number Publication Date
DK2212352T3 true DK2212352T3 (da) 2014-09-29

Family

ID=39226731

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08850370.1T DK2212352T3 (da) 2007-11-14 2008-11-10 Nye syntetiske argininsubstituerede peptider og deres anvendelse

Country Status (9)

Country Link
US (2) US7928185B2 (da)
EP (2) EP2060586A1 (da)
JP (1) JP2011503137A (da)
CN (1) CN101878226B (da)
AU (1) AU2008323041A1 (da)
CA (1) CA2703894A1 (da)
DK (1) DK2212352T3 (da)
MX (1) MX2010005280A (da)
WO (1) WO2009062898A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) * 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
WO2014090905A1 (en) * 2012-12-11 2014-06-19 Imaxio Modified coiled coil type proteins having improved properties
JP2016520534A (ja) 2013-03-18 2016-07-14 イマクシオＩｍａｘｉｏ インフルエンザ核タンパク質ワクチン
EP2989120A4 (en) 2013-04-25 2017-04-19 Carmel-Haifa University Economic Corp. Synthetic anti-inflammatory peptides and use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
AU665381B2 (en) 1992-01-23 1996-01-04 Morinaga Milk Industry Company Limited Antibacterial agent and treatment of article therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
CA2263416A1 (en) 1996-08-12 1998-02-19 A + Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
DK1228097T3 (da) * 1999-11-11 2006-04-18 Am Pharma Bv Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
WO2006047744A2 (en) 2004-10-26 2006-05-04 Agennix Incorporated Compositions of lactoferrin related peptides and uses thereof

Also Published As

Publication number Publication date
US20110224152A1 (en) 2011-09-15
EP2212352B1 (en) 2014-07-02
US20090186823A1 (en) 2009-07-23
US8815812B2 (en) 2014-08-26
WO2009062898A1 (en) 2009-05-22
MX2010005280A (es) 2010-08-31
CN101878226A (zh) 2010-11-03
JP2011503137A (ja) 2011-01-27
CA2703894A1 (en) 2009-05-22
EP2212352A1 (en) 2010-08-04
AU2008323041A1 (en) 2009-05-22
CN101878226B (zh) 2014-06-25
EP2060586A1 (en) 2009-05-20
US7928185B2 (en) 2011-04-19

Similar Documents

Publication Publication Date Title
DK2147096T3 (da) Modificerede faktor-VII-polypeptider og anvendelser deraf
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK2234985T3 (da) 4-(4-cyano-2-thioaryl)-dihydropyrimidinoner og deres anvendelse
DK2913344T3 (da) Specifikke bindingsproteiner og anvendelser deraf
DK2118140T3 (da) Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
DK3118221T3 (da) Proteiner
DK2437762T3 (da) Kunstige tårer og terapeutiske anvendelser
DK2240203T3 (da) Alfa5-beta1-antistoffer og deres anvendelser
DK2552434T3 (da) Peptider og anvendelse deraf
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
ATE543405T1 (de) Frisiergerät
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2391625T3 (da) Nye adenosinreceptorligander og anvendelser deraf
DK2687596T3 (da) Faktor VII-polypeptider som er modificerede og anvendelser deraf
DK2620075T4 (da) Hårsætningsaggregat
BRPI0813647A2 (pt) Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados
DK3338790T3 (da) Oligopeptid-forbindelser og anvendelser deraf
DK2185552T3 (da) Dipeptoid-prodrugs og anvendelse heraf
BR112012006501A2 (pt) polipeptídios e usos dos mesmos
DE602008004276D1 (de) Luftkanone
DK2120936T3 (da) Nye fremgangsmåder
DK2234976T3 (da) Nye pyrazol-substituerede arylamider
DK2190991T3 (da) SDF-1-Bindende nucleinsyrer og anvendelsen deraf
DK2158199T3 (da) Piperidinforbindelser og anvendelser deraf
DK2214487T3 (da) Nye sEH-inhibitorer og deres anvendelse